(Q24248660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Amantadine for dyskinesia in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Niall J Crosby

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Carl E Clarke

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Carl E Clarke

series ordinal

3

0 references

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

CD003467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

The effect of amantadine on levodopa-induced dyskinesias in Parkinson's disease: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

7 January 2021

Letters to the Editor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD003467

1 reference

7 January 2021

Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

7 January 2021

Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

7 January 2021

NMDA receptor blockade reverses motor response alterations induced by levodopa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

7 January 2021

Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003467

7 January 2021

10.1002/14651858.CD003467

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference